Hydrogen Bromide → HCID 18666630, compound
Reaction equation
C(O[CH:5]1[O:13][C@H:12]([CH2:14][O:15][C:16](=[O:18])[CH3:17])[C@@H:7]([O:8][C:9](=[O:11])[CH3:10])[C@H:6]1[Cl:19])(=O)C.[BrH:20]>ClCCl.C(O)(=O)C>[C:9]([O:8][C@@H:7]1[C@@H:12]([CH2:14][O:15][C:16](=[O:18])[CH3:17])[O:13][CH:5]([Br:20])[C@@H:6]1[Cl:19])(=[O:11])[CH3:10]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
3,5-Di-O-acetyl-2-chloro-2-deoxy-α,β-D-ribofuranosyl acetate (the compound described by J. P. Schaumberg et al., in "J. Org. Chem.," 50, pp. 1651-1656, 1985) represented by the following formula (N) ##STR52## where Ac is acetyl group is dissolved in dichloromethane. To the resulting solution is added 30% hydrogen bromide in acetic acid to effect the reaction at room temperature overnight. The resulting reaction solution is concentrated and the remaining acetic acid is removed by azeotropic distillation with toluene, to yield 3,5-di-O-acetyl-2-chloro-2-deoxy-α,β-D-ribofuranosyl bromide [compound (O)] as a syrup.
Workup
- customthe reaction at room temperature overnight
- customThe resulting reaction solution
- concentrationis concentrated
- customthe remaining acetic acid is removed by azeotropic distillation with toluene
Sources & evidence
- ORD record
- ord-0e736969bd7348828c9f884ba416e5ce
- Source dataset
- uspto-grants-1998_11
- Patent number
- US05831072
Reaction notes
Loading…